Literature DB >> 2978224

The in vivo behavior of T cell clones: altered migration due to loss of the lymphocyte surface homing receptor.

M O Dailey1, W M Gallatin, I L Weissman.   

Abstract

Although cloned lines of T lymphocytes have been valuable in defining the in vitro functions of well-defined cell types, they have often demonstrated relatively poor activity in vivo. One striking property of T cells clones which might affect their in vivo activity is their unusual inability to localized in lymphoid tissue as do most normal T cells. Normal lymphocyte recirculation and localization requires that lymphocytes recognize and pass through the walls of specialized high endothelial venules (HEV) as they enter into lymph nodes. We previously showed that murine T cell clones are unable to home into the peripheral lymphoid organs-lymph nodes and Peyer's patches. The inability of these cells to recognize lymph node HEV in an in vitro frozen section adherence assay suggested that the lack of lymphoid homing was due to the loss of a normal lymphocyte surface receptor for HEV. The present experiments were designed to determine: 1) the molecular mechanism responsible for the loss of normal lymphocyte migration, and 2) whether these migration and homing characteristics are irreversible features of T cell clones. Flow cytometric analysis of helper and cytolytic clones using a monoclonal antibody (MEL-14) specific for the lymphocyte homing receptor showed that they lack this surface receptor. This lack of receptor expression was confirmed by the inability to detect the antigen in detergent-solubilized extracts of surface-radiolabeled cells. Thus, the lack of homing to lymph nodes appears to be due to the loss of expression of the surface receptor which mediates the interaction between lymphocytes and HEV. When clones were rested in vitro in a nonproliferative state without stimulation by antigen or growth factors, they did not regain expression of the surface homing receptor or the ability to migrate to lymph nodes in vivo. The lack of receptor expression, therefore, is not merely associated with a rapidly proliferating state, but rather seems to be an irreversible feature of T cell clones, at least under in vitro culture conditions. T cell clones, both rested and recently restimulated, share certain features characteristic of activated T cells, as shown by recent results with MLC-stimulated T cell blasts. Both populations are large, brightly PNA-positive lymphocytes which lack expression of the MEL-14 receptor and do not home to peripheral lymphoid tissue. We propose that this PNA-high, MEL-14- nonrecirculating phenotype may represent a normal phase of T cell differentiation through which many T cells pass after being activated by specific antigen.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2978224

Source DB:  PubMed          Journal:  J Mol Cell Immunol        ISSN: 0724-6803


  18 in total

Review 1.  Immune control of the brain.

Authors:  M Bradl
Journal:  Springer Semin Immunopathol       Date:  1996

2.  Co-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunity.

Authors:  Antonia M S Müller; Sumana Shashidhar; Natascha J Küpper; Holbrook E K Kohrt; Mareike Florek; Robert S Negrin; Janice M Brown; Judith A Shizuru
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-22       Impact factor: 11.205

3.  Recognition of thyroglobulin autoantigenic epitopes by murine T and B cells.

Authors:  B R Champion; K Page; D C Rayner; R Quartey-Papafio; P G Byfield; G Henderson
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

Review 4.  Memory CD8+ T cell differentiation.

Authors:  Joshua J Obar; Leo Lefrançois
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

5.  CCR7/CCL19 controls expression of EDG-1 in T cells.

Authors:  Laura A Shannon; Tiffany M McBurney; Melissa A Wells; Megan E Roth; Psachal A Calloway; Charles A Bill; Shamima Islam; Charlotte M Vines
Journal:  J Biol Chem       Date:  2012-02-13       Impact factor: 5.157

6.  Protective immunity in murine histoplasmosis: functional comparison of adoptively transferred T-cell clones and splenic T cells.

Authors:  G S Deepe
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

7.  A murine model for B-lymphocyte somatic cell gene therapy.

Authors:  N Sutkowski; M L Kuo; A Varela-Echavarria; J P Dougherty; Y Ron
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

8.  Transfer of murine host protection by using interleukin-2-dependent T-lymphocyte lines.

Authors:  C C Paul; K Norris; R Warren; R A Smith
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

9.  Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer.

Authors:  R L Kradin; L A Boyle; F I Preffer; R J Callahan; M Barlai-Kovach; H W Strauss; S Dubinett; J T Kurnick
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

10.  Adoptive immunity to Mycobacterium bovis strain bacillus Calmette-Guérin by long-term cultured T-cell line in nude mice.

Authors:  S Yamamoto; H Iwai; K Ueda
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.